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Abstract: Cardiac troponin T (TnT) is a
regulatory contractile protein not normally
found in blood. Minor elevations of TnT in
patients with unstable angina have been
associated with an increased risk of
subsequent death or Acute Myocardial
Infarction (AMI). We used a neewly
developed enzyme immunoassay for TnT to
determine whether its presence in the serum
of patients with unstable angina was a
prognostic indicator. We screened 105
hatients with unstable angina (23 with
accelerated or subacute angina and, 82 with
acute angina at rest) for TnT every eight
hours for two days after admission to the
hospital. The outcomes of interest during the
hospitalization were death and myocardial
infarction. Troponin T was detected (range
0.20 to 3.64 µg per liter; mean 0.78;
median, 0.50) in the serum of 32 of the 82

patients. (39 percent) with acute angina at
rest. of the 33 patients who were positive for
TnT, 10 (30 percent) had myocardial
infarction (3 after coronary artery bypass
surgery), and 5 of these died during
hospitalization. In contrast only 1 of the 50
patients with angina at rest who were
negative for troponin T had an acute
myocardial infarction (p<0.001), and this
patient died (p=0.03). Thus, 10 of the 11
patients with myocardial infarctions had
detectable levels of TnT; troponin T was not
detected in any of the 23 paitents with
accelerated or subacute angina and none of
these patients died. Conclusion: Cardiac
troponin T is a cheap, simple and
prognostically very useful indicator in
patients with unstable angina.
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Introduction

Methods

Unstable angina is important cilinically because of its
frightening and disabling nature and the distinct
possibility that it heralds acute myocardial infarction (1)
Postmortem studies reveal that fatal events are
frequently preceded by the result of the fissuring of
atheromatous plaques with subsequent activation of
platelets, thrombus formation and episodic embolization
(1, 2).

Patients: The study population consisted of 105
consecutive patients (27 women and 78 men; mean age
(+SD), 61-10 years) who were admitted because of chest
pain during the last 72 h. and ST depr. or T-inv. in ECG
were included. All patients were followed for 6 months.
Patients with myocardial infarction documented within
the previous two weeks who had valvular heart diseease
or cardiomyopathy were excluded. Reviewers unaware of
the patients’troponin T values categorized them as
follows, using Braunwald’s classification of unstable
angina; (10 patients were assigued to class 1 (severe or
accelerated angina of new onset), 13 patients to class 2
(subacute angina at rest -i.e., not active within the
previous 48 hours) and 82 patients to calss 3 (angina at
rest during, the previous 48 hours).

Troponin T is a structurally bound protein found in
striated muscle cells. Cardiac troponin T can be
differentiated from its isoforms in skeletal muscle by
immunologic techniqus, and it is not detectable in the
serum of healthy people. Circulating troponin T is
therefore a highly sensitive and specific marker of
myocardial-cell injury (2-5).
Minor elevations of TnT in patients with unstable
angina have been associated with an increased risk of
subsequent death or acute myocardial infarction (4-6).

All the patients were given bed rest and an intensive
medical regimen that included nitrates (given orally in 81
paitents and intravenously in 55) beta blockers (61
patiens), and calcium-channel blockers (75 patients), All
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Standard 12-lead electrocardiography was performed
routinely at the time of admission and during episodes of
chest pain. The electrocardiograms were evalutade blindly
for evidence of reversible byocardial ischemia, defined as
transient ST elevation ST depression and T-wave
inversion.

Study Protocol
The study protocol was approved by the ethics
committee at the University of Erciyes After informed con
sent was obtained from esch patient, 10 ml of blood was
collected within six hours of admission to the hospital and
every eight hours there after for two days. The samples
were kept at room temperature for 20 minutes to allow
clotting, were centrifuged, and were then stored at 200˚C. The values listed for troponin T represent the
peak concentrations during each collection period.

Analytic techniques
The biochemical analysis was performed by
technicians unaware of the patients histories for the
quantitative determination, of serum troponin T an
enzyme immunologic assay (Boehringer, Germany) was
used. Based on a technique using streptavidin, this singlestep sandwich assay allows serial determination of blood
samples to be made within two hours, The test is carried
out in microprocessor-controlled photometers (E>22,
Boehringer and requires streptavidin-coated tubes as the
solid phase and two monoclonal antihuman cardiac
troponin T antibodies. During a 60-minute incubation
period, the antigen is bound by one biotinylated and one
peroxidase labeled antibody.
This complex adheres to the test-tube wall because of
the high-affinity streptavidin-biotin interaction. After two
washing steps, the substrate chromogen solution (ABTS,
Boehringer) is added. Substrate conversion im quantified
by the occurenece of a change in color at 405 mm, which
directly correlate with the concentration of troponin T in
the blood sample. The level of sensitivity of this test is
0.20 µg per liter. Values > 0.20 µg per liter were
considered positive for troponin T in this study.
Statistical Analysis
All the results are expressed as means+SD except as
stated otherwise, An exploratory analysis of data was
performed with the Freeman-Halton test (two tailed) in
the groups with and detectable levels of troponin T.
Continuous variables were analyzed with unpaired t-tests.
P values <0.05. were considered to indicate statistical
significance.
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Positive predicitive value was calculated as the number
of true positive test results, among all positive test results
observed, and negative predicitive value as the number of
true negative test resutls among all negative test results
observed.
Results
The 23 patients was with class 1 or 2 unstable angina.
In none of the 138 blood samples from these patients
was troponin T measurable, and these patients had no
cardiac events during hospitalization.
In contrast 32 (39 percent) of the 82 patients with
acute angina at rest (class 3) had measurable levels of
troponin T was measurable (at levels>0.20 µg per liter)
in the first or second sample obtained after admission. In
the remaining five patients, the first serum sample with
detectable level of troponin T was obtained 16 to 24
hours after admission and was associated with recurrent
episodes of angina at rest. two representative patterns of
troponin T release are shown in figure 1. In 50 of the 82
patients with angina at rest (61 percent) no troponin T
could be measured.
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the patiens received aspirin or heparin according to local
practice.
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Figure 1.

Representative patterns of Release of Troponin T in Patients
with Unstable Angina

The patients with and those without measurable levles
of troponin T did not differ with respect to baseline
clinical characteristics and treatment (table 1). Coronary
angiography in 62 patients with calss 3 angina revealed
comparable degrees of coronary disease in the groups
positive and negative for troponin T (table 1) The six
patients with normal coronary arteries had no
measurable troponin T in serum.
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Variable

Negative
(n=50

Positive
(n=32)

60±10
30-81
34/16

64±11
42-81
26/6

36
30
24
36
2
17
29

24
22
16
21
2
9
21

5
6
12
12

0
5
11
7

1

2

14

7

Table 1.

Clinical Data on 82 patients
with
Angina
at
Rest
(Braunwald Class 3) According
to Whether They Were
Negative or Positive for
Troponin T.

Table 2.

Interventions and Cardiac
Events during Hospitalization
in Patients with angina at rest
according to Whether. They
Were Negative or Positive for
Troponin T

Table 3.

Major Cardiac Events during
Hospitalization and Date of
Occurrence*

Age (yr)
Mean
Range
Sex (M) F
Medication used
Oral nitrates
Intravenous nitrates
Beta-blockers
Calcium-channel blockers
Heparin alone
Aspirin alone
Aspirin and Heparin
Angiographic Findings
No of vessels with stenosis ≥70%
0
1
2
3
Lenf main coronary artery
disease stenosis >50%
Angiography not performed
Electrocardiographic changen

Variable
Intervention
Angioplaty
Bypass grafting
Cardiac events
Acute infarction
Perioperative
Deaths
After infarction
After bypass graftingn

Negative
(n=50)

Positive
(n=32)

p
Value*

14
8

15
7

NS
NS

1
0
1
1
0

10
3
5
2
3

<0.001
0.03

* NS denotes not significant

Patient
No
1
2**
3
4
5
6
7
8
9
10
11

Age/Sex
48/M
57/M
79/F
72/M
58/F
74/M
78/M
71/M
67/M
76/M
65/M

Troponin T
µg/liter
0.37
0.20
0.22
1.09
0.48
0.53
0.29
0.80
1.05
0.89
0.32

Day, after
admission

Cardiac events
Infarction
Death after
Death after
Death after
Death after
Death after
Death after
Death after
Infarction
Infarction
Infarction

infarction
infarction
infarction
bypass surgey
bypass surgey
bypass surgey
bypass surgey

and
and
and
and

infarction
infarction
infarction
infarction

3
7
5
7
10
8
3
5
6
2
4

* Values of <0.20 mg perliter for troponin T were considered normal. Infaction denetes acute
myocardial infarction, and bypass surgery coronary artery bypass surgery
** This patient wes claccified as negative for troponin T
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During hospitalization, coronary angioplasty was
necessary in 30 patients (14 negative and 15 positive for
troponin T) and bypass surgery was performed in 16
patients (8 negative and 7 positive). The differences
between the groups were not statistically significant
(Table 2).
Clinical outcomes during hospitalization (duration,
21+7 days) were related to the presence of detectable
levels of serum troponin T, of the 33 patients who were
positive for troponin T 10 (30 percent) had acute
myocardial infarction within 2 to 10 days after
hospitalization that were associated with new ST
elevations (table 3). All patients with infarction were
treated with aspirin. In two patients (patients 10 and 11,
table 3) the vessel with an infarct could be opened by
coronary angioplasty within two hours after the onset of
symptoms. Three infarcts occured after coronary by pass
surgery and resulted in death. Five of the 33 patients who
were positive for troponin (15 percent) died during
hospitalization. In contrast, only 1 of the 50 patients who
were negative for troponin T (2 percent) had an acute
myocardial infaction; 17 occured seven days. After
admission, and the patient died. The incidence of
myocardial infarction (p<0.001) and death (p=0.03) was
significantly different between the groups positive and
negative for troponin T (table 2).
Ten of the 11 acute myocardial infarction were
preceded by the detection of measurable levels of serum
troponin T. The positive predictive value of a detectable
level of troponin T for acute myocardial infarction in this
population of patients was 30 percent, and the negative
predictive value was 98 percent. Of the 11 patients with
myocardial infarction, 8 had neasurable levels of troponin
T in the serum sample obtained within six hours of
admission. In two other patients (patients 1 and 7)
troponin T was first detected in the four th sample (on
day 2) after recurrent episodes of angina at rest (Table 3)
of the 62 serum samples obtained from these 11
patients, 51 had measurable levels of troponin T.
Discussion
Unstable angina is a critical phase of ischemic heart
disease, but there are no reliable, noninvasive methods of
assigning patients to different prognostic categories. An
unfavorable outcome has been linked with the occurence
of frequent episodes of symptomatic or silent myocardial
ischemia during 48 hours of intensive medicla therapy (7,
8). A subgroup of high-risk patients can be identified by
the detection of transient shifts of the ST-T segment on
serial electrocardiograms (9).
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Previous studies in patients have shown that higher
sensitivity and specificity for the detection of mycardialcell injury are provided by measurements of circulating
levels of cardial muscle, multiple isoforms of the
contractile proteins myosin and actin and the regulatory
proteins troponyosin and the troponin compyex have
been found (10). Among these proteins, troponin T and
troponin I appear to be unique cardiac antigens (10, 11,
12) Recently specific monoclonal antibodies have been
developed against cardiac troponin T that have essentially
no cross-reactivity with their isoforms in skeletal muscle
(12). The assay for troponin T used in this study allows
measurements in serum samples to be made within two
hours, and it therefore appears suitable for routine use
(12).
Troponin T was not elevated in serum samples from
patients with subcute or accelerated angina (classes 1 and
2 of braun wald (13). However troponin T was found in
39 percent of patients with persistent angina at rest
when blood samples were obtainde at eight-hour
intervals for two days after admission to the hospital.
(Ten of 11) in- hospital mycardial infarctions occurred in
patients whose serum was positive for troponin T.
Besides the unfavorable outcomes in patients with
measurable levels of troponin T who were treated
medically, our patients appeared to be at higher risk
during coronary-artery bypass surgery. Surgery in
patients with angina at rest that is refratory to medikal
treatemnt is known to be associated with higher
complication rates (14, 15). All three fatal perioperative
myocardial infarctions in out series occurred in petinets
with measurable levels of troponin T in the serum.
In unstable angina, reversible as well as irreversible
cell injury may occur. Troponin T is found in myocytes in
both a small free cytosolic pool and a langer structurally
bound fraction (16, 17). A loss of cell-membrane
integrity during severe ischemia results in only transient
leakage from the cytosolic pool, irreversible cell damage
with degradation of myofilaments, however is followed
by a delayed but continuous liberation of the bound
troponin T farction. Accordingly in acute mycardial
infacrtion, a biphasic pattedrn of release with peaks at
14, hours and three to five days has been demonstrated
(3, 17, 18). The presence of circulating cardiac proteins
in patients with unstable angina may be explained by the
intermittent critical reduction of flow as a result of
intracoronary thrombus formation, resulting in reversible
damage to the cell membrane, and also by minor local cell
necrosis due to thrombotic microembolization (5, 18).
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The present results suggest that measurement of
troponin T in serum allows a useful prediction of risk in
patients with unstable angina (19, 20) Cardiac risk during
hospitalization may be estimated by measurement of

troponin T soon after admission to the hospital, and such
measurement may help to guide decisions about
management.
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